Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Posts Increased Revenues, Earnings for Q1

This article has been updated from an earlier version that misstated the percentage of revenues from life science mass spectrometry systems.

 

NEW YORK, May 5 (GenomeWeb News) - Bruker BioSciences yesterday reported increased revenues and earnings for the first quarter of 2004.

 

Revenues for the quarter were $68.2 million, up from $63.1 million during the first quarter of 2003. Approximately 40 percenrt of these revenues resulted from life science mass spectrometry systems.

 

R&D expenses increased to $10.4 million, up from $8.8 million during the year-ago period.

 

Bruker's net earnings totaled $1 million, or $.01 per share, up from a net loss of $1.6 million, or $.02 per share, during the same quarter last year.

 

As of March 31, Bruker had $76.7 million in cash and short-term investments.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.